CATALOGO DEI PRODOTTI DELLA RICERCA

AMBROSETTI, Achille
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.286
EU - Europa 10.017
AS - Asia 6.793
SA - Sud America 853
Continente sconosciuto - Info sul continente non disponibili 193
AF - Africa 177
OC - Oceania 49
AN - Antartide 1
Totale 29.369
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.099
RU - Federazione Russa 2.988
SG - Singapore 2.713
GB - Regno Unito 2.652
CN - Cina 2.144
IT - Italia 1.081
DE - Germania 775
BR - Brasile 684
SE - Svezia 620
VN - Vietnam 547
FR - Francia 537
HK - Hong Kong 485
FI - Finlandia 443
IE - Irlanda 418
KR - Corea 203
UA - Ucraina 168
BD - Bangladesh 148
IN - India 121
CA - Canada 88
TR - Turchia 78
AR - Argentina 67
ID - Indonesia 54
JP - Giappone 50
AU - Australia 48
NL - Olanda 46
MX - Messico 44
NG - Nigeria 44
BE - Belgio 41
PL - Polonia 41
ES - Italia 39
ZA - Sudafrica 36
IR - Iran 32
IQ - Iraq 31
PK - Pakistan 27
CZ - Repubblica Ceca 26
EC - Ecuador 25
AT - Austria 21
SA - Arabia Saudita 21
VE - Venezuela 20
CO - Colombia 19
UZ - Uzbekistan 17
RO - Romania 16
MA - Marocco 15
GR - Grecia 14
EG - Egitto 13
CL - Cile 12
DZ - Algeria 12
MY - Malesia 12
AE - Emirati Arabi Uniti 11
LT - Lituania 11
NP - Nepal 11
AZ - Azerbaigian 10
PY - Paraguay 10
TN - Tunisia 10
ET - Etiopia 9
EU - Europa 9
PE - Perù 9
PT - Portogallo 9
LV - Lettonia 8
PH - Filippine 8
TH - Thailandia 8
AL - Albania 7
CH - Svizzera 7
CR - Costa Rica 7
DK - Danimarca 7
GH - Ghana 7
JM - Giamaica 7
PA - Panama 7
SY - Repubblica araba siriana 7
BG - Bulgaria 6
CG - Congo 6
DO - Repubblica Dominicana 6
KZ - Kazakistan 6
HN - Honduras 5
JO - Giordania 5
KE - Kenya 5
LK - Sri Lanka 5
NI - Nicaragua 5
NO - Norvegia 5
PS - Palestinian Territory 5
SI - Slovenia 5
BB - Barbados 4
HU - Ungheria 4
KG - Kirghizistan 4
LB - Libano 4
MD - Moldavia 4
OM - Oman 4
TW - Taiwan 4
UY - Uruguay 4
AM - Armenia 3
BO - Bolivia 3
BY - Bielorussia 3
CM - Camerun 3
EE - Estonia 3
GT - Guatemala 3
LU - Lussemburgo 3
SN - Senegal 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
Totale 29.142
Salva come PNG Salva come JPEG
Città #
Southend 2.234
Singapore 1.449
Jacksonville 1.286
Ashburn 1.154
Chandler 1.029
Moscow 918
Woodbridge 823
San Jose 809
Dallas 795
Ann Arbor 540
Hong Kong 479
Dublin 417
Houston 370
Beijing 313
The Dalles 310
Council Bluffs 294
Verona 246
Los Angeles 221
Wilmington 217
Jinan 193
New York 184
Buffalo 181
Lawrence 179
Princeton 179
Ho Chi Minh City 169
Nanjing 165
Shenyang 156
Hanoi 119
Boardman 102
Hebei 102
Helsinki 100
Milan 88
Tianjin 80
Santa Clara 78
São Paulo 75
Columbus 74
Sindelfingen 70
Zhengzhou 68
Munich 66
Changsha 58
Hangzhou 58
Seattle 58
Haikou 56
Rome 55
Taizhou 55
Nanchang 54
Philadelphia 53
Orem 50
Jiaxing 49
Guangzhou 48
Dong Ket 45
Ningbo 45
Falls Church 41
Tokyo 40
Abuja 39
Fairfield 39
Frankfurt am Main 39
Montreal 39
Brussels 38
Turku 37
Cambridge 35
Jakarta 34
Redondo Beach 34
London 31
Taiyuan 31
Norwalk 30
Warsaw 30
Brooklyn 29
Atlanta 28
Chennai 28
Lanzhou 28
Seoul 28
Perth 27
Dearborn 26
Fuzhou 25
Haiphong 25
Lancaster 25
Toronto 25
Bologna 24
Phoenix 23
Redwood City 22
Stockholm 22
Redmond 21
Rio de Janeiro 21
Denver 20
Manchester 20
San Francisco 20
Washington 20
Belo Horizonte 19
Chicago 18
Johannesburg 18
Auburn Hills 16
Provo 16
Tashkent 16
Boston 15
Brno 15
Dhaka 15
Düsseldorf 15
Mumbai 14
Amsterdam 13
Totale 18.250
Salva come PNG Salva come JPEG
Nome #
Immunocitologia e immunoistologia delle cellule midollari normali e neoplastiche 447
A simplified immunological approach to the diagnosis of chronic lymphocytic leukaemia and other lymphoproliferative disorders 295
Linfomi del tessuto linfatico associato alle mucose (MALT) delle ghiandole salivari. Descrizione di un caso in un paziente con infezione da virus C dell'epatite e revisione della letteratura 291
Clinical significance of LAIR1 (CD305) as assessed by flow cytometry in a prospective series of patients with chronic lymphocytic leukemia 288
BCR-ABL fusion transcript b2a2 is associated with a higher risk of non-optimal early response in CP-CML patients treated with standard dose imatinib: a study from Gruppo Triveneto LMC. 256
Prognostic value of serum markers of established impact on prognosis in relation with ZAP-70 expression in B-CLL patients 251
Acute leukemia and pregnancy. Case report 250
Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia 248
CAL2 Monoclonal Antibody Is a Rapid and Sensitive Assay for the Detection of Calreticulin Mutations in Essential Thrombocythemia and May Provide Prognostic Informations 248
Blood smear, a key diagnostic tool in hematology: Lessons from two cases of acute hemolysis in previously undiagnosed g6pd deficiency 246
A proliferation-inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B-cell chronic lymphocytic leukemia 243
Alpha-interferon activated cytotoxic lymphocytes in hairy cell leukemia patients: evaluation of cytotoxic events 240
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 238
Analisi del riarrangiamento bcr-abl in alcuni pazienti affetti da leucemia mieloide cronica 233
An assessment of chimeric transcript detection in CML patients after bone marrow transplantation 232
The diagnostic value of serum copper levels and other hematochemical parameters in malignancies 228
Double productive immunoglobulin sequence rearrangements in patients with chronic lymphocytic leukemia 227
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. 226
The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia 224
Alpha-interferon activates the natural killer system in patients with hairy cell leukemia 223
Serum levels of soluble interleukin-2 receptor in hairy cell leukaemia: a reliable marker of neoplastic bulk 223
CXCL8/interleukin 8 in B-cell chronic lymphocytic leukemia is up-regulated through the activity of the CXCL12/CXCR4 axis 222
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 221
Integrated single cell network profiling data of ERK signaling and mutations of SF3B1 gene refine prognosis in chronic lymphocytic leukemia 221
[Clinical and pathological staging of 85 patients with Hodgkin's disease: a clinical contribution (author's transl)] 217
Inhibition of Notch signalling overcomes bone marrow stromal-mediated anti-apoptotic and chemoresistance effects in AML. 217
Chronic graft versus host disease is associated with erectile dysfunction in allogeneic hematopoietic stem cell transplant patients: a single-center experience 216
CAL2 monoclonal antibody is a rapid and sensitive assay for the detection of calreticulin mutations in essential thrombocythemia and may provide prognostic informations 215
[The use of betamethasone in polychemotherapy of lymphoproliferative diseases] 214
PROGNOSTIC VALUE OF SERUM THYMIDINE KINASE LEVEL AND ZAP-70 EXPRESSION DETECTED BY IMMUNOHISTOCHEMISTRY ON BONE MARROW BIOPSIES IN B-CLL: COMPARATIVE ANALYSIS 214
Oral itraconazole plus nasal amphotericin B for prophylaxis of invasive aspergillosis in patients with hematological malignancies 211
Anemie iporigenerative ipercromiche e macrocitiche 210
Predictive factors of stable deep molecular response in chronic myeloid leukemia patients treated with imatinib standard dose: a study from the Gruppo Triveneto LMC. 208
[Liver and spleen involvement in Hodgkin's disease: critical evaluation of diagnostic procedures (author's transl)] 207
Different suppression of Ph1 positive hemopoiesis induced by intensive chemotherapy in lymphoid and myeloid blast crisis of CML 205
Combination of chemotherapy and radiotherapy improves the cure rate in primary extranodal lymphomas of the head and neck (PLHN) 203
Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: relationship with the effect of recombinant alpha-interferon therapy on clinical parameters and natural killer in vitro activity 203
Ceftazidime and amikacin as empiric antibiotic therapy of febrile granulocytopenic patients with hematological malignancies. Report of 171 consecutive episodes 203
Autoimmune cytopenias in chronic lymphocytic leukemia at disease presentation in the modern treatment era: is stage C always stage C? 203
An unusual case of acute leukaemia 202
Predictors of stable deep molecular response in chronic phase chronic myeloid leukemia patients treated with dasatinib or nilotinib after imatinib failure 202
Folic acid binding protein in chronic granulocytic leukaemia: the effect of methotrexate 201
Espressione del CD30 ligando sulle cellule di differenti neoplasie ematologiche leucemiche 197
Chirurgia e chemioterapia nel trattamento dei linfomi gastrici primitivi: revisione casistica 197
2-chlorodeoxyadenosine (2-CDA) therapy in previously untreated patients with follicular stage III-IV non-Hodgkin's lymphoma [see comments] 195
B cells in chronic lymphocytic leukaemia. Comparative analysis of blood and bone marrow 193
Monoterapia empirica con ceftazidime nelle infezioni di pazienti neutropenici affetti da emopatie maligne 192
CT imaging of primary pancreatic lymphoma: experience from three referral centres for pancreatic diseases 192
Prognostic factors in acute non-lymphocytic leukemia with respect to treatment response 191
THE COMBINATION OF SERUM THYMIDINE KINASE, B-2-MICROGLOBULIN AND SOLUBLE CD23 AT DIAGNOSIS IS PREDICTIVE FOR PROGRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA, INDEPENDENTLY FROM ZAP-70 EXPRESSION 191
Primary extranodal lymphomas of Waldeyer's ring, stage IE and IIE: Long-term survival after chemotherapy combined with radiotherapy 190
Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi 190
Soluble interleukin-2 receptor in the serum of patients with Hodgkin's Disease: A new biological marker of disease activity 189
Bone marrow transplantation monitoring by DNA analysis 188
Postoperative chemotherapy increases the disease-free survival rate in primary gastric lymphomas stage IE and IIE 187
CT IMAGING OF PRIMARY PANCREATIC LYMPHOMA 186
Leucemie 185
Combination of EUTOS score and 3-month BCR-ABL transcript level identifies a group of good-risk chronic myeloid leukemia patients with favorable response to frontline imatinib therapy 184
OFATUMUMAB AND LENALIDOMIDE PREFERENTIALLY INHIBIT B-CELL RECEPTOR SIGNALING IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS WITH MUTATED IGHV 183
A randomized, open-label, multicentre, phase 2/3 study to evaluate the safety and efficacy of lumiliximab in combination with fludarabine, cyclophosphamide and rituximab versus fludarabine, cyclophosphamide and rituximab alone in subjects with relapsed chronic lymphocytic leukaemia 183
Integration of B-cell receptor-induced ERK1/2 phosphorylation and mutations of SF3B1 gene refines prognosis in treatment naive chronic lymphocytic leukemia 182
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice 178
Imatinib-treated chronic myeloid leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response 177
Unicentric Castleman's lymphadenopathy presenting with Behcet's syndrome: a case report 176
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia 176
the International Extranodal Lymphoma Study group (IELSG). Intravascular lymphoma: clinical presentation, natural history, management, and prognostic factors in a series of 38 cases, with special emphasis on the “cutaneous variant”. 176
Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction 175
Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma. 174
Use of prothrombin complex concentrate for prophylaxis of bleeding in acquired factor X deficiency associated with light-chain amyloidosis 174
Real-life comparison of dasatinib and nilotinib as second-line therapy after imatinib failure for chronic phase CML 174
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma 174
Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lymphoma 173
Comparison of dasatinib and nilotinib as second-line therapy after imatinib failure in chronic phase chronic myeloid leukemia patients. 173
Mediastinal large-cell lymphoma of B-type, with sclerosis: histopathological and immunohistochemical study of eight cases 172
Detection of normal and malignant megakaryocytes by anti beta-thromboglobulin serum. An immunofluorescence study 172
Terminal transferase expression in relapsed acute myeloid leukaemia 171
Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience 171
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 170
Molecular “warning” CML patients: a retrospective study of Gruppo Triveneto LMC. 169
Multiple large osteolytic lesions in a patient with systemic mastocytosis: a challenging diagnosis 169
Aberrant methylation in the promoter region of the reduced folate carrier gene is a potential mechanism of resistance to methotrexate in primary central nervous system lymphomas. 166
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma 166
Mycobacterial infections preceding hairy-cell leukemia diagnosis. Description of two cases 165
Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease 165
Distribution and heterogeneity of cells detected by HNK-1 monoclonal antibody in blood and tissues in normal, reactive and neoplastic conditions 164
Regulation of the proliferative potential of cord blood long term culture initiating cells (LTC-IC) by different stromal cell lines: implications for LTC-IC measurement 164
Valutazione del significato della cupremia come indice di attività e come segno precoce di ricaduta nel cancro della mammella e nel morbo di Hodgkin (studio su 270 Casi). 164
BCR breakpoint subregions and blast crisis lineage in CML patients 164
Serum levels of soluble CD30 improve international prognostic score in predicting the outcome of advanced Hodgkin's lymphoma 163
Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients 162
Clinical value of PCR in diagnosis and follow-up of leukaemia and lymphoma: report of the Third Workshop of the Molecular Biology/BMT Study Group 162
The combination of Serum Thymidine Kinase, Beta-2-Microglobulin and soluble CD23 at diagnosis is predictive for progression in B-cell Chronic Lymphocytic Leukemia, independently from ZAP-70 expression 161
Epstein-Barr virus DNA load in chronic lymphocytic leukemia is an independent predictor of clinical course and survival 159
Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. 156
Soluble interleukin-2 receptor in hairy cell leukemia: A reliable marker of disease 155
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients 155
Patterns of outcome and prognostic factors in primary large cell lymphoma of the testis in a survey of 373 patients by the International Extranodal Lymphoma Study Grfoup (IELSG). 154
Pilot study of survival of patients with chronic myeloid leukemia after determination of intracellular folate binding protein (FABP) 153
ZAP-70 expression, as detected by immunohistochemistry on bone marrow biopsies from early-phase CLL patients, is a strong adverse prognostic factor. 153
Dasatinib-induced response in a rare case of chronic lymphocytic leukaemia associated with chronic myeloid leukaemia 153
Totale 19.865
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.556
article - articoli 74.807
book - libri 0
conference - conferenze 14.667
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.082
Totale 185.112
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022924 0 0 15 113 86 45 33 92 59 39 134 308
2022/20232.990 229 282 292 549 311 705 47 155 314 25 62 19
2023/20241.441 69 143 131 176 157 202 59 104 17 73 196 114
2024/20253.758 265 228 119 623 242 146 186 181 579 194 294 701
2025/202610.259 755 604 862 1.493 2.383 664 1.064 556 793 670 199 216
2026/2027564 208 278 78 0 0 0 0 0 0 0 0 0
Totale 29.369